Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 17:13:59.
doi: 10.1186/s12957-015-0473-1.

Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature

Affiliations
Review

Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature

Min-Ki Seong et al. World J Surg Oncol. .

Abstract

Primary apocrine sweat gland carcinoma (PASGC) is an extremely rare malignancy with a relatively favorable prognosis. PASGC is often suspected to be a benign disease during an initial clinical examination, which leads to inadequate initial treatment and extensive metastasis. Owing to the limited number of reports on PASGC, its diagnostic criteria and treatment guidelines have not yet been established. The only known curative therapy for localized PASGC is wide local excision. In the present report, we describe two cases of PASGC with locally aggressive disease that arose in the axilla and review the literature about its clinicopathological features, diagnosis, and treatment. Based on the findings of the current report, we suggest that a sentinel lymph node biopsy and adjuvant anti-estrogen therapy should be included in the management of PASGC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A photograph of the left axillary mass prior to excision. The mass, measuring 3 × 3 cm in size, was firm, erythematous, multilobular, indurated, and non-tender.
Figure 2
Figure 2
Microscopic features of the tumor cells. (A, B) The tumor cells contained abundant, granular, eosinophilic cytoplasm and enlarged nuclei with prominent nucleoli (hematoxylin and eosin stain, ×200).
Figure 3
Figure 3
Immunostaining for gross cystic disease fluid protein-15. (A, B) Diffuse cytoplasmic staining of gross cystic disease fluid protein-15 was observed in the tumor cells (×200).

References

    1. Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012;105:415–9. doi: 10.1002/jso.22023. - DOI - PubMed
    1. Vučinić I, Stojadinović T, Borić Mikez Z, Đanić D, Coha B. Apocrine carcinoma of the scalp with aggressive clinical course–a case report and review of the literature. Coll Antropol. 2013;36:209–12. - PubMed
    1. Pucevich B, Catinchi-Jaime S, Ho J, Jukic DM. Invasive primary ductal apocrine adenocarcinoma of axilla: a case report with immunohistochemical profiling and a review of literature. Dermatol Online J. 2008;14:5. - PubMed
    1. Chintamani, Sharma R, Badran R, Singhal V, Saxena S, Bansal A. Metastatic sweat gland adenocarcinoma: a clinico-pathological dilemma. World J Surg Oncol. 2003;1:13. doi: 10.1186/1477-7819-1-13. - DOI - PMC - PubMed
    1. Karaca S, Kulac M, Sahin O, Esme H, Solak O, Aktepe F. A rare cutaneous tumor of the axilla: apocrine adenocarcinoma. Indian J Dermatol. 2007;52:50. doi: 10.4103/0019-5154.31926. - DOI

LinkOut - more resources